Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 155 articles:
HTML format
Text format



Single Articles


    April 2017
  1. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Text format     Abstract available


  2. PACKER M, O'Connor C, McMurray JJ, Wittes J, et al
    Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    N Engl J Med. 2017 Apr 12. doi: 10.1056/NEJMoa1601895.
    PubMed     Text format     Abstract available


  3. BANGALORE S, Fayyad R, Laskey R, DeMicco DA, et al
    Body-Weight Fluctuations and Outcomes in Coronary Disease.
    N Engl J Med. 2017;376:1332-1340.
    PubMed     Text format     Abstract available


  4. KERALIYA A, Blankstein R
    Regression of Coronary Atherosclerosis with Medical Therapy.
    N Engl J Med. 2017;376:1370.
    PubMed     Text format    


  5. NISSEN SE
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1390.
    PubMed     Text format    


  6. GROSSER T
    Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
    N Engl J Med. 2017;376:1389.
    PubMed     Text format    


    March 2017
  7. KULLO IJ, Fan X, Ding K
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1192-3.
    PubMed     Text format    


  8. ELLISON DH
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194.
    PubMed     Text format    


  9. RAPPAPORT SM, Neophytou AM
    Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1193.
    PubMed     Text format    



  10. Genetic Risk, Lifestyle, and Coronary Artery Disease.
    N Engl J Med. 2017;376:1194-5.
    PubMed     Text format    


  11. KOBER L
    Complete Revascularization in ST-Elevation Myocardial Infarction?
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMe1702825.
    PubMed     Text format    


  12. SMITS PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, et al
    Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    N Engl J Med. 2017 Mar 18. doi: 10.1056/NEJMoa1701067.
    PubMed     Text format     Abstract available


  13. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    PubMed     Text format     Abstract available


  14. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available


  15. DULLAART RP
    PCSK9 Inhibition to Reduce Cardiovascular Events.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
    PubMed     Text format    


  16. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available


  17. BELLEYCOTE EP, Lamy AR, Whitlock RP
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1087-8.
    PubMed     Text format    


  18. CHRISTIANSEN EH, Makikallio T, Holm NR
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1088-9.
    PubMed     Text format    



  19. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1089.
    PubMed     Text format    


  20. LIKOSKY DS, Baker RA
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894.
    PubMed     Text format    


  21. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    PubMed     Text format    



  22. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    PubMed     Text format    


  23. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    PubMed     Text format    



  24. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2017;376:894-895.
    PubMed     Text format    


  25. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    PubMed     Text format    



  26. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    PubMed     Text format    


    December 2016
  27. FARSHID A
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2604.
    PubMed     Text format    


  28. URBAN P, Oldroyd K, Krackhardt F
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2603-2604.
    PubMed     Text format    



  29. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602-2605.
    PubMed     Text format    


  30. BANGALORE S
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    N Engl J Med. 2016;375:2602-3.
    PubMed     Text format    


  31. VORA AN, Rao SV, Stone GW
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2602.
    PubMed     Text format    


  32. TAGGART DP, Altman DG, Gray AM, Lees B, et al
    Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.
    N Engl J Med. 2016;375:2540-9.
    PubMed     Text format     Abstract available


  33. BATES ER
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016;375:2605.
    PubMed     Text format    


  34. KHERA AV, Emdin CA, Drake I, Natarajan P, et al
    Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.
    N Engl J Med. 2016;375:2349-2358.
    PubMed     Text format     Abstract available


  35. O'DONNELL M, Mann JF, Schutte AE, Staessen JA, et al
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    PubMed     Text format    



  36. Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2404-2408.
    PubMed     Text format    


  37. JOHNS DM
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2407.
    PubMed     Text format    


  38. GRAUDAL N
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405-6.
    PubMed     Text format    


  39. ALDERMAN MH
    Dietary Sodium and Cardiovascular Disease Risk.
    N Engl J Med. 2016;375:2405.
    PubMed     Text format    


  40. SNIDERMAN AD, Thanassoulis G
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304.
    PubMed     Text format    


  41. MORRISON AC, Fu YP, O'Donnell CJ
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303.
    PubMed     Text format    



  42. Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2306.
    PubMed     Text format    


  43. STITZIEL NO
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2306.
    PubMed     Text format    


  44. MORIERI ML, Shah H, Doria A
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2304-2305.
    PubMed     Text format    


  45. HEGELE RA
    Variants in ANGPTL4 and the Risk of Coronary Artery Disease.
    N Engl J Med. 2016;375:2303-2304.
    PubMed     Text format    


  46. CONTOU D, de Prost N
    Skin Mottling.
    N Engl J Med. 2016;375:2187.
    PubMed     Text format    


    November 2016
  47. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    PubMed     Text format    


  48. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    PubMed     Text format    



  49. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    PubMed     Text format    


  50. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    PubMed     Text format    


    October 2016
  51. BRAUNWALD E
    Treatment of Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format    


  52. STONE GW, Sabik JF, Serruys PW, Simonton CA, et al
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  53. MYLES PS, Smith JA, Forbes A, Silbert B, et al
    Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  54. LAMY A, Devereaux PJ, Prabhakaran D, Taggart DP, et al
    Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  55. MOSLEHI JJ
    Cardiovascular Toxic Effects of Targeted Cancer Therapies.
    N Engl J Med. 2016;375:1457-1467.
    PubMed     Text format    


  56. BUCHOLZ EM, Butala NM, Ma S, Normand ST, et al
    Life Expectancy after Myocardial Infarction, According to Hospital Performance.
    N Engl J Med. 2016;375:1332-1342.
    PubMed     Text format     Abstract available


    September 2016
  57. DWYER T, Sinaiko AR, Raitakari OT
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    


  58. SHARMA A, Lavie C
    Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    



  59. Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016;375:1299-301.
    PubMed     Text format    


  60. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  61. RAZA S, Blackstone EH, Sabik JF 3rd
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    


  62. BARBATO E, Toth GG, De Bruyne B
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    



  63. Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;375:e22.
    PubMed     Text format    


  64. GIANNONI A, Emdin M, Passino C
    Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea.
    N Engl J Med. 2016;375:1004-6.
    PubMed     Text format    


    August 2016
  65. BATES ER
    Balancing the Evidence Base on Coronary Stents.
    N Engl J Med. 2016.
    PubMed     Text format    


  66. BONAA KH, Mannsverk J, Wiseth R, Aaberge L, et al
    Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  67. MOKHLESI B, Ayas NT
    Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives?
    N Engl J Med. 2016.
    PubMed     Text format    


  68. MCEVOY RD, Antic NA, Heeley E, Luo Y, et al
    CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  69. HU K, Xu W, Williams Z
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703-4.
    PubMed     Text format    


  70. DOEHNER W, Anker SD
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:703.
    PubMed     Text format    


  71. BURSZTYN M
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:702-3.
    PubMed     Text format    


  72. VISCOLI CM, Kernan WN, Young LH
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016;375:704.
    PubMed     Text format    


  73. BROTT TG, Voeks JH, Howard VJ
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:604-5.
    PubMed     Text format    


  74. HUSSAIN MA, Al-Omran M
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603.
    PubMed     Text format    


  75. PARASKEVAS KI
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:602.
    PubMed     Text format    


  76. SAMANTA A, Afzal MR
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:601-2.
    PubMed     Text format    


  77. MATSUMURA J, Monteleone P, Rosenfield K
    Stenting versus Surgery for Carotid Stenosis.
    N Engl J Med. 2016;375:603-4.
    PubMed     Text format    


  78. CHEN GC, Qin LQ
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    PubMed     Text format    


  79. KOPEL E
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:488.
    PubMed     Text format    


  80. LEOW MK
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:487-8.
    PubMed     Text format    


  81. DU H, Li L, Chen Z
    Fruit Consumption and Cardiovascular Disease in China.
    N Engl J Med. 2016;375:489.
    PubMed     Text format    



  82. Sharing Data from Cardiovascular Clinical Trials--A Proposal.
    N Engl J Med. 2016;375:407-9.
    PubMed     Text format    


    July 2016

  83. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    PubMed     Text format     Abstract available


  84. BASSAN M
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292-3.
    PubMed     Text format    


  85. WANITSCHEK MM, Dorler J, Alber HF
    Chronic Stable Angina.
    N Engl J Med. 2016;375:292.
    PubMed     Text format    


  86. OHMAN EM
    Chronic Stable Angina.
    N Engl J Med. 2016;375:293.
    PubMed     Text format    


  87. LI WW, Wollersheim LW, Morshuis WJ
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91.
    PubMed     Text format    


  88. ALKHODAIR A, Cairns J
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:90-1.
    PubMed     Text format    


  89. MYLES PS, Smith JA, Painter T
    Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;375:91-2.
    PubMed     Text format    


    June 2016
  90. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  91. RADEMAKERS LM, Van Nunen LX
    IMAGES IN CLINICAL MEDICINE. Ventricular Septal Defect after Acute Myocardial Infarction.
    N Engl J Med. 2016;374:e28.
    PubMed     Text format    


  92. COGSWELL ME, Mugavero K, Bowman BA, Frieden TR, et al
    Dietary Sodium and Cardiovascular Disease Risk - Measurement Matters.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  93. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    PubMed     Text format    


  94. NIOI P, Sigurdsson A, Thorleifsson G, Helgason H, et al
    Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  95. TYBJAERG-HANSEN A
    The Sialylation Pathway and Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available



  96. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016;374:1898.
    PubMed     Text format    


  97. SAPP JL, Wells GA, Parkash R, Stevenson WG, et al
    Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    April 2016

  98. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  99. TWIG G, Yaniv G, Levine H, Leiba A, et al
    Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  100. DU H, Li L, Bennett D, Guo Y, et al
    Fresh Fruit Consumption and Major Cardiovascular Disease in China.
    N Engl J Med. 2016;374:1332-43.
    PubMed     Text format     Abstract available


  101. SEMENKOVICH CF
    Insulin Resistance and a Long, Strange Trip.
    N Engl J Med. 2016;374:1378-9.
    PubMed     Text format    


  102. VELAZQUEZ EJ, Lee KL, Jones RH, Al-Khalidi HR, et al
    Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  103. GUYTON RA, Smith AL
    Coronary Bypass - Survival Benefit in Heart Failure.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  104. MICHLER RE, Smith PK, Parides MK, Ailawadi G, et al
    Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  105. LONN EM, Bosch J, Lopez-Jaramillo P, Zhu J, et al
    Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  106. YUSUF S, Bosch J, Dagenais G, Zhu J, et al
    Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  107. YUSUF S, Lonn E, Pais P, Bosch J, et al
    Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    March 2016
  108. KEANEY JF JR, Solomon CG
    Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence.
    N Engl J Med. 2016;374:1279-80.
    PubMed     Text format    


  109. HODIS HN, Mack WJ, Henderson VW, Shoupe D, et al
    Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    N Engl J Med. 2016;374:1221-31.
    PubMed     Text format     Abstract available


  110. OHMAN EM
    CLINICAL PRACTICE. Chronic Stable Angina.
    N Engl J Med. 2016;374:1167-76.
    PubMed     Text format    


  111. KERSTEN S
    The Genetics of Dyslipidemia--When Less Is More.
    N Engl J Med. 2016;374:1192-3.
    PubMed     Text format    


  112. DEROSA G, Maffioli P
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1095.
    PubMed     Text format    


  113. TSUTSUMI Y, Tsujimoto Y, Ikenoue T
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1094-5.
    PubMed     Text format    


  114. PFEFFER MA, Claggett B, Probstfield JL
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1095-6.
    PubMed     Text format    


  115. ROSENSTEIN R, Hough A
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1093-4.
    PubMed     Text format    


  116. EDWARDS JL
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1093.
    PubMed     Text format    


  117. FISCHEREDER M, Schonermarck U
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1092-3.
    PubMed     Text format    


  118. SARAFIDIS PA, Tsapas A
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1092.
    PubMed     Text format    


  119. ZINMAN B, Lachin JM, Inzucchi SE
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1094.
    PubMed     Text format    


  120. SPENCE JD, Naylor AR
    Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis.
    N Engl J Med. 2016;374:1087-8.
    PubMed     Text format    


  121. BROTT TG, Howard G, Roubin GS, Meschia JF, et al
    Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.
    N Engl J Med. 2016;374:1021-31.
    PubMed     Text format     Abstract available


  122. TOMODA H
    Polymer-free Drug-Coated Coronary Stents.
    N Engl J Med. 2016;374:892-3.
    PubMed     Text format    


  123. CAVALCANTE R, Sotomi Y, Onuma Y
    Polymer-free Drug-Coated Coronary Stents.
    N Engl J Med. 2016;374:892.
    PubMed     Text format    


  124. CHANDRASEKHAR J, Mehran R
    Polymer-free Drug-Coated Coronary Stents.
    N Engl J Med. 2016;374:891-2.
    PubMed     Text format    


  125. URBAN P, Morice MC
    Polymer-free Drug-Coated Coronary Stents.
    N Engl J Med. 2016;374:893.
    PubMed     Text format    


  126. NAMANA V, Balasubramanian R
    IMAGES IN CLINICAL MEDICINE. Right Ventricular Infarction.
    N Engl J Med. 2016;374:872.
    PubMed     Text format    



  127. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  128. DEWEY FE, Gusarova V, O'Dushlaine C, Gottesman O, et al
    Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  129. MYLES PS, Smith JA, Forbes A, Silbert B, et al
    Stopping vs. Continuing Aspirin before Coronary Artery Surgery.
    N Engl J Med. 2016;374:728-37.
    PubMed     Text format     Abstract available


  130. KERNAN WN, Viscoli CM, Furie KL, Young LH, et al
    Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  131. JONES DS, Greene JA
    Is Dementia in Decline? Historical Trends and Future Trajectories.
    N Engl J Med. 2016;374:507-9.
    PubMed     Text format    


  132. ALMADDAH N, Ajayi TO
    IMAGES IN CLINICAL MEDICINE. Cocaine-Induced Coronary-Artery Vasospasm.
    N Engl J Med. 2016;374:e5.
    PubMed     Text format    


    January 2016
  133. SHAH R
    Bivalirudin in Acute Coronary Syndromes.
    N Engl J Med. 2016;374:285.
    PubMed     Text format    


  134. VALGIMIGLI M, Santucci A
    Bivalirudin in Acute Coronary Syndromes. Authors reply.
    N Engl J Med. 2016;374:285-6.
    PubMed     Text format    


  135. SURDACKI A, Kruszelnicka O, Bednarek J
    Bivalirudin in Acute Coronary Syndromes.
    N Engl J Med. 2016;374:284-5.
    PubMed     Text format    


  136. BERNARDI P, Di Lisa F
    Cyclosporine before PCI in Acute Myocardial Infarction.
    N Engl J Med. 2016;374:89-90.
    PubMed     Text format    


  137. ZOGRAFOS TA, Katritsis DG
    Cyclosporine before PCI in Acute Myocardial Infarction.
    N Engl J Med. 2016;374:89.
    PubMed     Text format    


  138. POTTECHER J, Diemunsch P, Geny B
    Cyclosporine before PCI in Acute Myocardial Infarction.
    N Engl J Med. 2016;374:88-9.
    PubMed     Text format    


  139. SANTOS-GALLEGO CG, Badimon JJ
    Cyclosporine before PCI in Acute Myocardial Infarction.
    N Engl J Med. 2016;374:88.
    PubMed     Text format    


  140. MEWTON N, Bergerot C, Ovize M
    Cyclosporine before PCI in Acute Myocardial Infarction.
    N Engl J Med. 2016;374:90.
    PubMed     Text format    


  141. VAN ROOIJ E
    Cardiac Repair after Myocardial Infarction.
    N Engl J Med. 2016;374:85-7.
    PubMed     Text format    


    December 2015
  142. KAY GN
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  143. KUMAR HK
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  144. RUTTER MK, Wright AK, Ashcroft DM
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available



  145. Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  146. PFEFFER MA, Claggett B, Diaz R, Dickstein K, et al
    Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2015;373:2247-57.
    PubMed     Text format     Abstract available


    November 2015
  147. INGELFINGER JR, Rosen CJ
    Cardiovascular Risk and Sodium-Glucose Cotransporter 2 Inhibition in Type 2 Diabetes.
    N Engl J Med. 2015;373:2178-9.
    PubMed     Text format     Abstract available


  148. BOSELLO S, De Luca G, Ferraccioli G
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1977-8.
    PubMed     Text format    


  149. FARDMAN A
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1977.
    PubMed     Text format    


  150. KAVSAK PA
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1976-7.
    PubMed     Text format    


  151. LIPPI G, Targher G, Cervellin G
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1976.
    PubMed     Text format    


  152. EVERETT BM, Brooks MM, Bhatt DL
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1978-9.
    PubMed     Text format    


  153. SEDLIS SP, Hartigan PM, Teo KK, Maron DJ, et al
    Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
    N Engl J Med. 2015;373:1937-46.
    PubMed     Text format     Abstract available


  154. ADIGOPULA S, Nsair A
    Images in Clinical Medicine. Left Main Coronary Artery Stent Migration.
    N Engl J Med. 2015;373:1957.
    PubMed     Text format     Abstract available


  155. BYRNE RA
    Bioresorbable Vascular Scaffolds--Will Promise Become Reality?
    N Engl J Med. 2015;373:1969-71.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: